New registry aims to unlock pneumonia mysteries in vulnerable patients

NCT ID NCT06755814

Recruiting now Knowledge-focused Sponsor: Societa Italiana di Pneumologia Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is observing about 1,300 hospitalized adults with weakened immune systems who have pneumonia. Researchers will track their health for one year, looking at causes, treatments, and outcomes. The goal is to gather information to improve care for this high-risk group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors better predict and manage pneumonia in people with weakened immune systems.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly test new therapies. Results may not apply to all patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COMMUNITY-ACQUIRED PNEUMONIA (CAP) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Community-Acquired Pneumonia pneumonia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COMMUNITY-ACQUIRED PNEUMONIA (CAP)

Contacts and locations

Locations

Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Center, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico Milano Via Francesco Sforza 35 20122 Milan Italy
RECRUITING

Milan, Milano, 20122, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.